| Literature DB >> 32316985 |
Congli Tang1, Ziyu He1, Hongmei Liu1, Yuyue Xu1, Hao Huang1, Gaojian Yang1, Ziqi Xiao1, Song Li2, Hongna Liu1, Yan Deng1,3, Zhu Chen1, Hui Chen1, Nongyue He3.
Abstract
Nucleic acid is the main material for storing, copying, and transmitting genetic information. Gene sequencing is of great significance in DNA damage research, gene therapy, mutation analysis, bacterial infection, drug development, and clinical diagnosis. Gene detection has a wide range of applications, such as environmental, biomedical, pharmaceutical, agriculture and forensic medicine to name a few. Compared with Sanger sequencing, high-throughput sequencing technology has the advantages of larger output, high resolution, and low cost which greatly promotes the application of sequencing technology in life science research. Magnetic nanoparticles, as an important part of nanomaterials, have been widely used in various applications because of their good dispersion, high surface area, low cost, easy separation in buffer systems and signal detection. Based on the above, the application of magnetic nanoparticles in nucleic acid detection was reviewed.Entities:
Keywords: Clinical diagnosis; High-throughput sequencing; Magnetic nanoparticles; Magnetic separation; Nucleic acid detection
Mesh:
Substances:
Year: 2020 PMID: 32316985 PMCID: PMC7171821 DOI: 10.1186/s12951-020-00613-6
Source DB: PubMed Journal: J Nanobiotechnology ISSN: 1477-3155 Impact factor: 10.435
A summary of extraction
| Magnetic particles | Experimental sample | Extraction target | References |
|---|---|---|---|
| Fe3O4@Ag | HeLa, A549, MCF-7 | microRNA | [ |
| Fe3O4@SiO2 | Hep G2 | DNA/RNA | [ |
| MBs@SiO2 | E. coli, breast cancer | DNA | [ |
| MNPs | DNA | [ | |
| MBs | Liver cancer cells, | DNA | [ |
| Au@MNPs | A549 | microRNA | [ |
Fig. 1The schematic procedure of the integrated bacterial enrichment/gene-sensing system with Fe3O4/vancomycin/PEG nanocarrier [109]
Fig. 2Schematic illustration of the MS-MRS sensor [110]
Fig. 3Schematic illustrations of a one-step preparation of AuNCs@Van, and b determination of SA in mixtures using the Apt-MB and AuNCs@Van dual recognition strategy [113]
A summary of enrichment
| Magnetic particles | Experimental sample | Detection limit | References |
|---|---|---|---|
| Fe3O4/Vancomycin/PEG | 10 cfu/mL | [ | |
| MBs | 100 cfu/mL | [ | |
| Pt/MNCs | 10 cfu/mL | [ | |
| Au@MNPs | 10 cells/mL | [ | |
| AuNCs@Van | 70 cfu/mL | [ | |
| MNPs | 0.2 cells/mL | [ | |
| Fe3O4 | 10 cfu/mL | [ | |
| MNPs | 5 cfu/mL | [ | |
| Fe3O4 | AFP | 0.3 pg/mL | [ |
| CEA | 0.35 pg/mL | ||
| MNPs | HCT-116, MCF7 | – | [ |
| Fe3O4 | MCF-7, HepG2, Caco2 | – | [ |
| IO–FA | SKOV3, A549 | (4–10) × 106 cells/L, (3.5–5) × 109 cells/L | [ |
A summary of infectious detection
| Magnetic particles | Experimental sample | Detection limit | References |
|---|---|---|---|
| MBs | Group B streptococci | 1.25 × 103 cfu/mL | [ |
| MBs | 1 cfu/mL | [ | |
| MBs | CPV-2 | 3 × 104 copies/mL | [ |
| MNPs | H9N2, H1N1, H7N9 | 2 × 10−2 pg/mL | [ |
| SiO2@ MNPs | HBV, HCV, HIV-1 | 10, 10, 100 cfu/mL | [ |
| MBs | Chagas disease, human brucellosis, bovine brucellosis, foot-and-mouth disease | – | [ |
| GMBN | 5 × 105 cfu/mL | [ | |
| MBs | – | [ | |
| MBs | 3.125 × 103 ng/μL | [ | |
| 1 × 103 cells/mL | |||
| AuMagNBs | Influenza virus A | 4.42 × 10−14 g/mL | [ |
Fig. 4Schematic illustration of the real-time LCR DNA assay [146]
Fig. 5Schematic illustration of the proposed strategy for methylation detection [158]